Evidence map›Paper›PMID 35722548›Full record

ArticleFrontiers in psychiatry2022

Deep Learning in Neuroimaging: Overcoming Challenges With Emerging Approaches.

Jason Smucny, Ge Shi, Ian Davidson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Causal graph neural networks for healthcare.Nature biomedical engineering · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Deep learning in fetal, infant, and toddler neuroimaging research.Developmental cognitive neuroscience · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jason SmucnyDepartment of Psychiatry and Behavioral Sciences, University of California, Davis, Davis, CA, United States.
Ge ShiDepartment of Computer Sciences, University of California, Davis, Davis, CA, United States.
Ian DavidsonDepartment of Computer Sciences, University of California, Davis, Davis, CA, United States.
University of California, Davis · US

Funding

Predictive Markers and Mechanisms of Persistent Psychotic-like Experiences in Children: An Adolescent Brain and Cognitive Development Study AnalysisK01MH125096 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SMUCNY, JASON · 2021 to 2025
$872k
NIMH NIH HHS K01 MH125096
6 · The paper itself

Abstract

Deep learning (DL) is of great interest in psychiatry due its potential yet largely untapped ability to utilize multidimensional datasets (such as fMRI data) to predict clinical outcomes. Typical DL methods, however, have strong assumptions, such as large datasets and underlying model opaqueness, that are suitable for natural image prediction problems but not medical imaging. Here we describe three relatively novel DL approaches that may help accelerate its incorporation into mainstream psychiatry research and ultimately bring it into the clinic as a prognostic tool. We first introduce two methods that can reduce the amount of training data required to develop accurate models. These may prove invaluable for fMRI-based DL given the time and monetary expense required to acquire neuroimaging data. These methods are (1)

Indexed as

deep learningexplainable AIfMRImixup data augmentationtransfer learning

Identifiers

PMID35722548
PMCPMC9200984
OpenAlexW4281667947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.